Federal Register / Vol. 69, No. 193 / Wednesday, October 6, 2004 / Notices 59941

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Maternofetal 

Signaling and Lifelong Consequences. 

Date: November 1, 2004. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Gopal M. Bhatnagar, PhD, 

Scientific Review Administrator, National 

Institute of Child Health, and Human 

Development, National Institutes of Health, 

6100 Bldg., Rm. 5B01, Rockville, MD 20852, 

(301) 435–6889, bhatnagg@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS.)

Dated: September 29, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22410 Filed 10–5–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, 

Research Training Grants IV. 

Date: November 4, 2004. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points by Sheraton Bethesda, 

8400 Wisconsin Avenue, Bethesda, MD 

20814. 

Contact Person: Aileen Schulte, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd. Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1225, 

aschulte@mail.nih.gov.

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, 

Exploratory Research Grants. 

Date: November 4, 2004. 

Time: 3 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (telephone 

conference call). 

Contact Person: Bettina D. Acuna, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd. Room 6154, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1340, 

acunab@mail.nih.gov.

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, 

Research Training I. 

Date: November 10, 2004. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Peter J. Sheridan, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd. Room 6142, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–1513, 

psherida@mail.nih.gov.

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel, 

ZMH1 ERB–X–01, Training II. 

Date: November 23, 2004. 

Time: 11:30 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Benjamin Xu, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd. Room 6143, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1178, 

benxu1@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS.) 

Dated: September 29, 2004. 

Laverne Y. Stringfield 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22414 Filed 10–5–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel, Pharmacology. 

Date: October 25–26, 2004. 

Time: 5 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Chapel Hill Hotel, One 

Europe Drive, Chapter Hill, NC 27514. 

Contact Person: Shiva P. Singh, PhD, 

Scientific Review Administrator, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, Natcher Building, Room 3AN–12C, 

Bethesda, MD 20892, (301) 594–2272, 

singhs@nigms.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS)

Dated: September 29, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22415 Filed 10–5–04; 8:45 am] 

BILLING CODE 4140–01–M